Please provide your email address to receive an email when new articles are posted on . Capvaxive is made to protect against strains of pneumococcus bacteria that cause disease in adults. A CDC ...

NEW YORK (AP) — A scientific panel on Wednesday recommended that people 50 and older get a shot against bacteria that can cause pneumonia and other dangerous illnesses. If the recommendation is ...

This electron microscopic image provided by the Centers for Disease Control and prevention depicts two, round-shaped, Gram-positive, Streptococcus pneumoniae bacteria. (Janice Haney Carr/CDC via AP) ...

The Centers for Disease Control and Prevention (CDC) now recommends that American adults over the age of 50 receive the pneumococcal conjugate vaccine, or PCV. The report with the updated ...

Merck & Co. Inc. (NYSE:MRK) on Thursday released results from the Phase 3 STRIDE-13 trial evaluating Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) at the European Society of Clinical ...

RAHWAY, N.J.--(BUSINESS WIRE)-- Merck, known as MSD outside of the United States and Canada, today announced positive results from the Phase 3 STRIDE-13 trial evaluating CAPVAXIVE ® (Pneumococcal ...

The Gram-positive bacterium known as Streptococcus pneumoniae causes pneumococcal disease, which is transmitted via respiratory droplets and has a number of clinical manifestations that include ...

Sanofi SNY and its partner SK bioscience announced that they have expanded their agreement to develop, license and commercialize next-generation pneumococcal conjugate vaccines (PCVs) for treating ...

May 12, 2011 — Giving pneumococcal and herpes zoster vaccines to patients during the same visit may be beneficial without compromising the protective effect of the zoster vaccine, according to the ...

U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause pneumonia and other dangerous illnesses. The recommendation was made by a scientific ...